Want to see CCM full AI Analyst Report?
Total Valuation
Concord Medical Services has a market cap or net worth of $19.06M. The enterprise value is $3.34B.
Market Cap$19.06M
Enterprise Value$3.34B
Share Statistics
Concord Medical Services has 2,815,458 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,815,458
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Concord Medical Services’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is -4.26%.
Return on Equity (ROE)0.04
Return on Assets (ROA)-0.01
Return on Invested Capital (ROIC)-4.26%
Return on Capital Employed (ROCE)-0.05
Revenue Per Employee773.97K
Profits Per Employee-637.68K
Employee Count595
Asset Turnover0.07
Inventory Turnover9.46
Valuation Ratios
The current PE Ratio of Concord Medical Services is ―. Concord Medical Services’s PEG ratio is 0.00060.
PE Ratio―
PS Ratio0.00853
PB Ratio>-0.01
Price to Fair Value>-0.01
Price to FCF-0.01
Price to Operating Cash Flow0.00
PEG Ratio0.00060
Income Statement
In the last 12 months, Concord Medical Services had revenue of 460.51M and earned -92.81M in profits. Earnings per share was -621.00.
Revenue460.51M
Gross Profit25.82M
Operating Income-239.33M
Pretax Income-373.36M
Net Income-92.81M
EBITDA-71.77M
Earnings Per Share (EPS)-621.00
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Concord Medical Services pays an annual dividend of $0.99, resulting in a dividend yield of ―
Dividend Per Share$0.99
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.44
52-Week Price Change-22.44%
50-Day Moving Average4.73
200-Day Moving Average4.53
Relative Strength Index (RSI)43.58
Average Volume (3m)25.64K
Important Dates
Concord Medical Services upcoming earnings date is Sep 26, 2025, Before Open (Confirmed).
Last Earnings DateSep 27, 2024
Next Earnings DateSep 26, 2025
Ex-Dividend Date―
Financial Position
Concord Medical Services as a current ratio of 0.48, with Debt / Equity ratio of -172.84%
Current Ratio0.48
Quick Ratio0.46
Debt to Market Cap882.00
Net Debt to EBITDA-46.50
Interest Coverage Ratio-1.57
Taxes
In the past 12 months, Concord Medical Services has paid 6.06M in taxes.
Income Tax6.06M
Effective Tax Rate-0.02
Enterprise Valuation
Concord Medical Services EV to EBITDA ratio is -46.55, with an EV/FCF ratio of -11.40.
EV to Sales7.26
EV to EBITDA-46.55
EV to Free Cash Flow-11.40
EV to Operating Cash Flow-16.55
Balance Sheet
Concord Medical Services has $177.39M in cash and marketable securities with $3.82B in debt, giving a net cash position of -$3.65B billion.
Cash & Marketable Securities$177.39M
Total Debt$3.82B
Net Cash-$3.65B
Net Cash Per Share-$1.29K
Tangible Book Value Per Share$4.42K
Margins
Gross margin is 5.54%, with operating margin of -51.97%, and net profit margin of -20.15%.
Gross Margin5.54%
Operating Margin-51.97%
Pretax Margin-81.07%
Net Profit Margin-20.15%
EBITDA Margin-15.59%
EBIT Margin-48.00%
Analyst Forecast
The average price target for Concord Medical Services is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast20.26%
EPS Growth Forecast69.68%